{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:18:27Z","timestamp":1740143907019,"version":"3.37.3"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>This study aimed to investigate and provide insight into the prevalence and patterns of off-label drug use in the pediatric population from the perspective of community pharmacists, addressing the existing data gap in a developing setting.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A questionnaire-based cross-sectional study was conducted on Albanian community pharmacists in June 2021. The online administered survey explored the participants\u2019 demographic details, perceptions, and experiences with off-label prescriptions in pediatric patients. The statistical analysis conducted on the survey data comprised the construction of frequency tables and the application of the chi-square test for independence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>Three hundred and thirty-six community pharmacists nationwide completed the survey, out of which 186 (55.3%) were practiced in Tirana, the capital of Albania. Over 80% of surveyed pharmacists (n = 275) had encountered off-label drug prescriptions in pediatric patients, yet only 40% of participants reported dispensing medicines for off-label use. Community pharmacists reported that general pediatricians tended to prescribe off-label medications more frequently than pediatric subspecialists or general practitioners. It was found that off-label prescriptions were more frequently observed among children aged between 2 and 11 years. Antibiotics were the most reported medicines for off-label use in this study mentioned in almost all off-label categories.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Prescribing medicines for unapproved uses for the treatment of pediatric patients is present in community settings in Albania. This indicates the need for further data collection and analysis to understand off-label practices in our country\u2019s pediatric population comprehensively.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ijpp\/riae031","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T07:27:09Z","timestamp":1720164429000},"page":"355-362","source":"Crossref","is-referenced-by-count":1,"title":["Perceptions and experiences of community pharmacists with off-label prescribing in the pediatric population"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1290-3998","authenticated-orcid":false,"given":"Fabiola","family":"Noga","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Medicine Tirana , Tiran\u00eb, AL 1005 , Albania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1193-5357","authenticated-orcid":false,"given":"Ela","family":"Hoti","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Medicine Tirana , Tiran\u00eb, AL 1005 , Albania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0956-215X","authenticated-orcid":false,"given":"Eliana","family":"Ibrahimi","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Tirana , Tiran\u00eb, AL 1001 , Albania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Toma","sequence":"additional","affiliation":[{"name":"Order of Pharmacists of Albania , Tiran\u00eb, AL 1007 , Albania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9916-9858","authenticated-orcid":false,"given":"Ledjan","family":"Malaj","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Medicine Tirana , Tiran\u00eb, AL 1005 , Albania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,7,4]]},"reference":[{"key":"2024090317015070400_CIT0001","first-page":"776","article-title":"Off-label medication use in children, more common than we think: a systematic review of the literature","volume":"111","author":"Allen","year":"2018","journal-title":"J Okla State Med Assoc"},{"key":"2024090317015070400_CIT0002","doi-asserted-by":"crossref","first-page":"adv00660","DOI":"10.2340\/actadv.v101.981","article-title":"Physician-reported clinical unmet needs, burden and treatment patterns of paediatric psoriasis patients: a US and EU real-world evidence study","volume":"102","author":"Seyger","year":"2022","journal-title":"Acta Derm Venereol"},{"key":"2024090317015070400_CIT0003","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/jrpp.JRPP_18_42","article-title":"Off-label prescribing of antipsychotics in a Danish Child and Adolescent Mental Health Center: a register-based study","volume":"7","author":"Korn\u00f8","year":"2018","journal-title":"J Res Pharm Pract"},{"key":"2024090317015070400_CIT0004","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2147\/JPR.S195788","article-title":"The challenge of developing pain medications for children: therapeutic needs and future perspectives","volume":"12","author":"Eerdekens","year":"2019","journal-title":"J Pain Res"},{"key":"2024090317015070400_CIT0005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bcp.12305","article-title":"Clinical trials in children: clinical trials in children","volume":"79","author":"Joseph","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"2024090317015070400_CIT0006","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2125.2000.00125.x","article-title":"Drug trials in children: problems and the way forward","volume":"49","author":"Conroy","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"2024090317015070400_CIT0007"},{"key":"2024090317015070400_CIT0008","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s12519-018-0186-y","article-title":"Two decades of off-label prescribing in children: a literature review","volume":"14","author":"Balan","year":"2018","journal-title":"World J Pediatr"},{"key":"2024090317015070400_CIT0009","doi-asserted-by":"crossref","first-page":"e2019089","DOI":"10.1542\/peds.2019-0896","article-title":"Trends in off-label drug use in ambulatory settings: 2006\u20132015","volume":"144","author":"Hoon","year":"2019","journal-title":"Pediatrics"},{"key":"2024090317015070400_CIT0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/pds.5354","article-title":"Off-label drug use in neonates and infants in Spain: a five-year observational study","volume":"31","author":"Lizano-D\u00edez","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"first-page":"1","year":"2017","author":"Weda","key":"2024090317015070400_CIT0011"},{"key":"2024090317015070400_CIT0012","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00431-019-03556-9","article-title":"Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European Society for Developmental Perinatal and Pediatric Pharmacology","volume":"179","author":"Schrier","year":"2020","journal-title":"Eur J Pediatr"},{"author":"Official Journal of the European Union","key":"2024090317015070400_CIT0013","first-page":"1"},{"key":"2024090317015070400_CIT0014"},{"key":"2024090317015070400_CIT0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/archdischild-2017-313309","article-title":"More medicines for children: impact of the EU paediatric regulation","volume":"103","author":"Nordenmalm","year":"2018","journal-title":"Arch Dis Child"},{"key":"2024090317015070400_CIT0016","doi-asserted-by":"crossref","first-page":"593281","DOI":"10.3389\/fmed.2021.593281","article-title":"Paediatric medicines in Europe: the paediatric regulation-is it time for reform","volume":"8","author":"Toma","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2024090317015070400_CIT0017","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/pharmaceutics13040588","article-title":"Effects of the off-label drug prescription in the paediatric population in Spain from the adoption of the latest European Regulation: a pre","volume":"13","author":"Lizano-D\u00edez","year":"2021","journal-title":"Pharmaceutics"},{"key":"2024090317015070400_CIT0018","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1208\/s12249-016-0584-1","article-title":"European Paediatric Formulation Initiative (EuPFI)-formulating ideas for better medicines for children","volume":"18","author":"Salunke","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"2024090317015070400_CIT0019","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/jcpt.12119","article-title":"Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation","volume":"39","author":"Lindell-Osuagwu","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"2024090317015070400_CIT0020","doi-asserted-by":"crossref","first-page":"892574","DOI":"10.3389\/fphar.2022.892574","article-title":"Recommendations on off label drug use in pediatric guidelines","volume":"13","author":"Meng","year":"2022","journal-title":"Front Pharmacol"},{"key":"2024090317015070400_CIT0021","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/cpt.2736","article-title":"Off-label, but on-evidence? A review of the level of evidence for pediatric pharmacotherapy","volume":"112","author":"Van der Zanden","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"2024090317015070400_CIT0022","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/pharmacy6020051","article-title":"Community pharmacy use by children across Europe: a narrative literature review","volume":"6","author":"Blair","year":"2018","journal-title":"Pharmacy (Basel)"},{"key":"2024090317015070400_CIT0023"},{"key":"2024090317015070400_CIT0024","volume-title":"Sampling Techniques","author":"Cochran","year":"1963","edition":"2"},{"key":"2024090317015070400_CIT0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2125.2007.02865.x","article-title":"Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey","volume":"64","author":"Stewart","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"2024090317015070400_CIT0026","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00228-010-0978-z","article-title":"Healthcare professional experiences and attitudes on unlicensed\/off-label pediatric prescribing and pediatric clinical trials","volume":"67","author":"Mukattash","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"2024090317015070400_CIT0027","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12887-019-1664-7","article-title":"Current practice and awareness of pediatric off-label drug use in Shanghai, China: a questionnaire-based study","volume":"19","author":"Mei","year":"2019","journal-title":"BMC Pediatr"},{"year":"2017","key":"2024090317015070400_CIT0028"},{"key":"2024090317015070400_CIT0029"},{"key":"2024090317015070400_CIT0030","first-page":"33","article-title":"Exploratory findings of prescribing unlicensed and off-label medicines among children and neonates","volume":"9","author":"Shakeel","year":"2020","journal-title":"Integr Pharm Res Pract"},{"key":"2024090317015070400_CIT0031","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/jphs.12271","article-title":"Off-label medicine use in children, a study of community pharmacists in Jordan","volume":"9","author":"Mukattash","year":"2018","journal-title":"J Pharm Health Serv Res"},{"key":"2024090317015070400_CIT0032","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40272-018-0318-9","article-title":"Serious adverse events associated with off-label use of azithromycin or fentanyl in children in intensive care units: a retrospective chart review","volume":"21","author":"Oshikoya","year":"2019","journal-title":"Paediatr Drugs"},{"key":"2024090317015070400_CIT0033","doi-asserted-by":"crossref","first-page":"e22325","DOI":"10.2196\/22325","article-title":"Including the reason for use on prescriptions sent to pharmacists: scoping review","volume":"8","author":"Mercer","year":"2021","journal-title":"JMIR Hum Factors"},{"key":"2024090317015070400_CIT0034","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.jpeds.2016.04.037","article-title":"Maternal and child health care services in Albania","volume":"177","author":"Bali","year":"2016","journal-title":"J Pediatr"},{"key":"2024090317015070400_CIT0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3233\/JRS-150654","article-title":"Paediatric off-label and unlicensed prescribing in primary care in Malta: prospective observational drug utilisation study","volume":"27","author":"Ellul","year":"2015","journal-title":"Int J Risk Saf Med"},{"key":"2024090317015070400_CIT0036","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00431-013-2111-7","article-title":"Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches","volume":"172","author":"Carnovale","year":"2013","journal-title":"Eur J Pediatr"},{"key":"2024090317015070400_CIT0037","first-page":"51","article-title":"Paediatric status and off-label use of drugs in children in Italy, United Kingdom and the Netherlands","volume":"11","author":"Sturkenboom","year":"2009","journal-title":"Pharm Policy Law"},{"key":"2024090317015070400_CIT0038","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s11096-016-0306-5","article-title":"Maltese prescribers use of off-label and unlicensed medicines in children: perceptions and attitudes","volume":"38","author":"Ellul","year":"2016","journal-title":"Int J Clin Pharm"},{"key":"2024090317015070400_CIT0039","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.acap.2008.11.010","article-title":"Off-label prescribing to children in the United States outpatient setting","volume":"9","author":"Bazzano","year":"2009","journal-title":"Acad Pediatr"},{"key":"2024090317015070400_CIT0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.rpped.2015.06.008","article-title":"Frequency of prescriptions of off-label drugs and drugs not approved for pediatric use in primary health care in a southern municipality of Brazil","volume":"34","author":"Gon\u00e7alves","year":"2016","journal-title":"Rev Paul Pediatr"},{"key":"2024090317015070400_CIT0041","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1179\/204690513X13656734979929","article-title":"Off-label and unlicensed paediatric prescribing in a community setting: a prospective longitudinal cohort study in Malta","volume":"34","author":"Ellul","year":"2014","journal-title":"Paediatr Int Child Health"},{"key":"2024090317015070400_CIT0042","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00228-010-0842-1","article-title":"Off-label antibiotic use in children in three European countries","volume":"66","author":"Porta","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"2024090317015070400_CIT0043","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/2042098614554919","article-title":"Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem","volume":"5","author":"Llor","year":"2014","journal-title":"Ther Adv Drug Saf"},{"author":"Unlicensed Medicines","key":"2024090317015070400_CIT0044"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/32\/5\/355\/59004906\/riae031.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/32\/5\/355\/59004906\/riae031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T01:43:00Z","timestamp":1725414180000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/article\/32\/5\/355\/7706425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,7,4]]},"published-print":{"date-parts":[[2024,9,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ijpp\/riae031","relation":{},"ISSN":["0961-7671","2042-7174"],"issn-type":[{"type":"print","value":"0961-7671"},{"type":"electronic","value":"2042-7174"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,7,4]]}}}